rxstat › Shortages › Darifenacin

Darifenacin shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Darifenacin products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 10, 2026.
Products affected
1 / 6
In shortage since
May 26, 2026
Est. full return
Jul 10, 2026
Reports on file
15
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-DARIFENACIN
7.5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452510 · since May 26, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP DARIFENACIN
7.5MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02491869 · ended Apr 9, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-DARIFENACIN
7.5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452510 · ended Oct 10, 2024 · Disruption of the manufacture of the drug.
Resolved
ENABLEX
15MG · TABLET (EXTENDED-RELEASE) · SEARCHLIGHT PHARMA INC
DIN 02273225 · ended Aug 26, 2024 · Shortage of an active ingredient.
Resolved
APO-DARIFENACIN
15MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452529 · ended Jul 4, 2024 · Disruption of the manufacture of the drug.
Resolved
ENABLEX
7.5MG · TABLET (EXTENDED-RELEASE) · SEARCHLIGHT PHARMA INC
DIN 02273217 · ended Jun 28, 2024 · Shortage of an active ingredient.
Resolved
JAMP DARIFENACIN
7.5MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02491869 · ended Jun 17, 2024 · Disruption of the manufacture of the drug.
Resolved
JAMP DARIFENACIN
15MG · TABLET (EXTENDED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02491877 · ended Jun 17, 2024 · Disruption of the manufacture of the drug.
Resolved
ENABLEX
15MG · TABLET (EXTENDED-RELEASE) · MERUS LABS LUXCO S. A R.L.
DIN 02273225 · ended Nov 15, 2018 · Other (Please describe in comments)
Resolved
APO-DARIFENACIN
15MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452529 · ended Jan 31, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-DARIFENACIN
7.5MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02452510 · ended Jan 21, 2022 · Disruption of the manufacture of the drug.
Resolved
ENABLEX
7.5MG · TABLET (EXTENDED-RELEASE) · MERUS LABS LUXCO S. A R.L.
DIN 02273217 · ended Jan 2, 2019 · Other (Please describe in comments)

Showing 12 of 15 reports. All reports are on file with Health Canada.

What's happening

Darifenacin is currently affected by an active shortage report filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Darifenacin is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BD).

Recent changes

Common questions

When will Darifenacin be back in stock in Canada?

The latest manufacturer estimate is Jul 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Darifenacin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other urologicals, incl antispasmodics)

Widespread shortageAlprostadil3 of 5 reported products affectedWidespread shortageFlavoxate2 of 2 reported products affectedWidespread shortageMirabegron2 of 2 reported products affected · est. return Jul 3, 2026Widespread shortageTolterodine8 of 16 reported products affected · est. return Sep 8, 2026Partial shortageFesoterodine1 of 4 reported products affected · est. return Jan 29, 2027Partial shortageOxybutynin Chloride2 of 11 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.